Alterations in free fatty acid (FFA) concentrations could provide a chemotactic stimulus for macrophage infiltration through arachidonic acid products or the release of chemokines, such as monocyte chemoattractant protein-1 (MCP-1) [11,12]
Appetite control becomes more pronounced, portion sizes decrease naturally, and cravings for high-calorie foods diminish
Retatrutide has not received Health Canada approval and remains in Phase 3 clinical trials globally
(28) The crude incidence rates of amputation were 6.1 per 10,000 person-years for GLP-1s, 1.5 for SGLT-2 inhibitors, 4.6 for DPP4-Is, and 1.9 for other agents
This affects how quickly GLP-1 medications are absorbed and metabolized
It was found, though, that people who took Topamax started to notice weight loss (2) in addition to reducing the number of seizures that they had